Editing
Antibody Design by AI
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Library Design and Contruction == Single framework library generation A gene fragment encoding the germline framework combination IGHV3-23 and IGKV1-39 was synthesized by Invitrogen’s GeneArt service in Fab format and cloned into a phagemid vector serving as the base template. IGHV3-23 and IGKV1-39 were used as they display a favorable framework combination for a phage display library and this framework combination is used in several therapeutic antibodies including trastuzumab and bevacizumab (Tiller et al., 2013). The phagemid vector consists of Ampicillin resistance, ColE1 origin, M13 origin and a bi-cistronic expression cassette under a lac promotor with OmpA - light chain followed by PhoA–heavy chain – '''Amber stop''' – truncated pIII (amino acids '''231 – 406'''). Only '''CDR-H3 '''was diversified and primers were designed to incorporate '''all naturally occurring amino acids excluding cysteine '''(free cysteines could form disulfide bonds), '''and asparagine''' (asparagine in conjunction with certain amino acids could undergo deamidation or become glycosylated) using trinucleotide technology (ELLA Biotech). Lengths between '''10 and 16 amino acids and 18 '''amino acids were allowed, in which the last two amino acids were kept constant with the sequence '''Asp-Tyr''' for length '''10 to 16''' and '''Asp-Val''' for length '''18'''. The design of the final two CDR-H3 amino acids reflects human VDJ recombination. '''Short CDR-H3s''' more often use J-fragment '''IGHJ4''' with “'''DY'''” at the end of CDRH3 while '''longer '''CDR-H3s (here 18 aa) more often use '''IGHJ6 '''with “'''DV'''” at the end of CDR-H3. Library inserts were generated by '''PCR''' using '''Phusion '''High Fidelity DNA polymerase (NEB Biolabs). The resulting CDR-H3 library inserts were ligated into the base template, transformed into E.coli '''TG1 DUO''' (Lucigen) with a minimal library size of '''1E+09''' transformants per CDRH3 length and phages were produced using '''M13KO7''' helper phage (NEB Biolabs) using standard previously described protocols (Proetzel and Ebersbach, 2016).
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages